Clinical Evaluation of a Tubal Selective Delivery System

Inclusion Criteria: * Literate in English * Able to understand and sign an IRB-approved informed consent form * Willing to complete a pre-procedure questionnaire * Regular menstrual cycles (24- 38 days) * Good general health * Able and willing to comply with all study tests, procedures, and assessment tools * Uterine sound size between 6 - 10 cm * Agree to use a non-hormonal method of contraception or avoid vaginal intercourse during the catheter evaluation cycle * In compliance with cervical cancer screening guidelines per the American Society for Colposcopy and Cervical Pathology (ASCCP) guidelines without evidence of disease. Alternatively, the subject must have had a colposcopy performed within the appropriate screen time frame, and prior to the study catheter insertion that showed no evidence of dysplasia requiring treatment or further diagnostic procedures or follow-up for at least 6 months Exclusion Criteria: * Currently pregnant as confirmed by positive high-sensitivity urine pregnancy test * Currently using hormonal contraception. Must have at least one natural cycle (two menses) prior to participation if recently discontinued hormonal contraception. * Currently using an intrauterine device (IUD). Must discontinue at least 30 days prior to Visit 2 * Allergy or hypersensitive to radio-opaque contrast, ExEm foam, both doxycycline and azithromycin (allergy to one not exclusionary if can take the alternative), or lidocaine * History or physical findings recognized as…